RE:Xtract with a new R&D contract You understand that this is an R&D research grant to Xtract, a company PAT paid $6,000,000 and the issuance of 9,422,956 Patriot One common shares and continues to report a goodwill value of
$ 22,993,819
As such an R&D revenue they receive is peanuts compared to what they paid out for the company